UK markets closed
  • FTSE 100

    -20.90 (-0.28%)
  • FTSE 250

    -215.13 (-0.94%)
  • AIM

    -11.87 (-1.01%)

    +0.0011 (+0.09%)

    -0.0030 (-0.22%)

    -170.87 (-0.54%)
  • CMC Crypto 200

    +12.02 (+1.17%)
  • S&P 500

    +3.82 (+0.08%)
  • DOW

    -201.81 (-0.56%)

    +2.15 (+2.62%)

    -4.10 (-0.23%)
  • NIKKEI 225

    -364.85 (-1.28%)

    -46.45 (-0.19%)
  • DAX

    -148.35 (-0.93%)
  • CAC 40

    -58.14 (-0.81%)

Insights on the Translational Regenerative Medicine Global Market to 2026 - Featuring Anika Therapeutics, Celgene and Medipost Among Others

·6-min read

Dublin, Jan. 04, 2022 (GLOBE NEWSWIRE) -- The "Translational Regenerative Medicine Market Research Report by Product Type, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Translational Regenerative Medicine Market size was estimated at USD 2,198.67 million in 2020 and expected to reach USD 2,439.43 million in 2021, at a CAGR of 11.28% to reach USD 4,176.97 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Translational Regenerative Medicine to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product Type, the market was studied across Cell Based Product, Gene Therapy Product, and Tissue Engineered Product.

  • Based on Application, the market was studied across Cardiovascular, Dermatology, Diabetes, Neurology, Oncology, and Orthopedic.

  • Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and the United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Translational Regenerative Medicine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Translational Regenerative Medicine Market, including Anika Therapeutics, Athersys, Inc., Brainstorm Cell Therapeutics Inc., Celgene Corporation, Gamida Cell Ltd., Medipost, Novartis, Nuvasive, Inc., Orthofix International N.V, and Vericel Corporation.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Translational Regenerative Medicine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Translational Regenerative Medicine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Translational Regenerative Medicine Market?
4. What is the competitive strategic window for opportunities in the Global Translational Regenerative Medicine Market?
5. What are the technology trends and regulatory frameworks in the Global Translational Regenerative Medicine Market?
6. What is the market share of the leading vendors in the Global Translational Regenerative Medicine Market?
7. What modes and strategic moves are considered suitable for entering the Global Translational Regenerative Medicine Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Increasing incidence of chronic and genetic related diseases worldwide Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism Rising geriatric population coupled with associated diseases
5.1.2. Restraints High cost of the treatment and operational inefficiency
5.1.3. Opportunities Ongoing research in the organ transplantation with regenerative medicine Favorable reimbursement policies and technological advancements
5.1.4. Challenges Stringent regulations and compliance mandates for approval
5.2. Cumulative Impact of COVID-19

6. Translational Regenerative Medicine Market, by Product Type
6.1. Introduction
6.2. Cell Based Product
6.3. Gene Therapy Product
6.4. Tissue Engineered Product

7. Translational Regenerative Medicine Market, by Application
7.1. Introduction
7.2. Cardiovascular
7.3. Dermatology
7.4. Diabetes
7.5. Neurology
7.6. Oncology
7.7. Orthopedic

8. Americas Translational Regenerative Medicine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Translational Regenerative Medicine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Translational Regenerative Medicine Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Anika Therapeutics
12.2. Athersys, Inc.
12.3. Brainstorm Cell Therapeutics Inc.
12.4. Celgene Corporation
12.5. Gamida Cell Ltd.
12.6. Medipost
12.7. Novartis
12.8. Nuvasive, Inc.
12.9. Orthofix International N.V
12.10. Vericel Corporation

13. Appendix

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting